2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer and Infectious Diseases
Cancer and infectious diseases share a complex relationship, as certain infections can increase the risk of developing cancer, while cancer treatments may trigger infections. Chronic viral infections, such as those caused by the human papillomavirus (HPV), hepatitis B, and C, are strongly linked to specific cancers, including cervical, liver, and throat cancer. Research in this field explores how these infections promote cancer development by causing genetic mutations, immune system dysfunction, and persistent inflammation. Vaccines like the HPV vaccine have become a powerful tool in preventing cancer caused by viral infections. Additionally, scientists are examining the role of the microbiome in cancer development, as infections can alter the balance of microbial communities, potentially influencing cancer progression. Efforts are also focused on developing antiviral therapies that not only treat infections but also reduce cancer risk, offering new prevention and treatment possibilities.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China